Back to GetFilings.com



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 10-Q

 

(Mark one)

ý

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

 

For the quarterly period ended February 29, 2004

 

 

 

OR

 

 

 

o

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

 

For the transition period from             to             

 

Commission File Number 000-26565

 


 

LIBERATE TECHNOLOGIES

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware

 

94-3245315

(State or Other Jurisdiction of Incorporation)

 

(I.R.S. Employer Identification No.)

 

 

 

2655 Campus Drive, Suite 250, San Mateo,
California

 

94403

(Address of Principal Executive Offices)

 

(Zip Code)

 

 

 

(650) 645-4000

(Registrant’s Telephone Number, Including Area Code)

 

2 Circle Star Way, San Carlos, California 94070

(Former Address)

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý  No o

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).  Yes ý  No o

 

105,479,192 shares of the Registrant’s common stock were outstanding as of March 31, 2004.

 

 



 

LIBERATE TECHNOLOGIES

FORM 10-Q

For The Quarterly Period Ended February 29, 2004

TABLE OF CONTENTS

 

PART I.

FINANCIAL INFORMATION

 

Item 1.

Financial Statements (Unaudited)

 

 

Condensed Consolidated Balance Sheets as of February 29, 2004 and May 31, 2003

 

 

Condensed Consolidated Statements of Operations for the three months and nine months ended February 29, 2004 and February 28, 2003

 

 

Condensed Consolidated Statements of Cash Flows for the nine months ended February 29, 2004 and February 28, 2003

 

 

Notes to Condensed Consolidated Financial Statements

 

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

 

 

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

 

 

 

 

Item 4.

Controls and Procedures

 

 

 

 

PART II.

OTHER INFORMATION

 

 

 

 

Item 1.

Legal Proceedings

 

 

 

 

Item 6.

Exhibits and Reports on Form 8-K

 

 

 

 

SIGNATURES

 

 



 

Part I. Financial Information

 

Item 1. Financial Statements

 

LIBERATE TECHNOLOGIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands)

Unaudited

 

 

 

February 29,
2004

 

May 31,
2003

 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

222,299

 

$

261,689

 

Accounts receivable, net

 

3,835

 

3,310

 

Prepaid expenses and other current assets

 

2,273

 

3,069

 

Assets of discontinued operations

 

 

6,936

 

Total current assets

 

228,407

 

275,004

 

Property and equipment, net

 

4,270

 

6,113

 

Intangible assets, net

 

 

22

 

Deferred costs related to warrants

 

4,479

 

14,449

 

Restricted cash

 

10,876

 

9,249

 

Other assets

 

324

 

131

 

Total assets

 

$

248,356

 

$

304,968

 

 

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

1,848

 

$

1,888

 

Accrued liabilities

 

19,522

 

39,442

 

Accrued payroll and related expenses

 

1,380

 

1,562

 

Deferred revenues

 

10,415

 

10,619

 

Liabilities of discontinued operations

 

 

5,375

 

Total current liabilities

 

33,165

 

58,886

 

Long-term excess facilities charges

 

19,631

 

22,330

 

Other long-term liabilities

 

2,373

 

2,242

 

Total liabilities

 

55,169

 

83,458

 

Commitments and contingencies (Note 7)

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Common stock

 

1,055

 

1,040

 

Contributed and paid-in-capital

 

1,501,597

 

1,490,125

 

Deferred stock-based compensation

 

(7,589

)

(194

)

Accumulated other comprehensive income (loss)

 

(2,011

)

1,804

 

Accumulated deficit

 

(1,299,865

)

(1,271,265

)

Total stockholders’ equity

 

193,187

 

221,510

 

Total liabilities and stockholders’ equity

 

$

248,356

 

$

304,968

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

1



 

LIBERATE TECHNOLOGIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

Unaudited

 

 

 

Three months ended

 

Nine months ended

 

 

 

February 29,
2004

 

February 28,
2003

 

February 29,
2004

 

February 28,
2003

 

Revenues:

 

 

 

 

 

 

 

 

 

License and royalty

 

$

(54

)

$

2,077

 

$

(1,675

)

$

5,633

 

Service

 

1,756

 

3,250

 

6,110

 

14,692

 

Total revenues

 

1,702

 

5,327

 

4,435

 

20,325

 

Cost of revenues:

 

 

 

 

 

 

 

 

 

License and royalty

 

206

 

257

 

565

 

1,101

 

Service

 

1,549

 

4,240

 

4,360

 

21,464

 

Total cost of revenues

 

1,755

 

4,497

 

4,925

 

22,565

 

Gross margin (loss)

 

(53

)

830

 

(490

)

(2,240

)

Operating expenses:

 

 

 

 

 

 

 

 

 

Research and development

 

5,022

 

5,485

 

12,336

 

21,865

 

Sales and marketing

 

703

 

4,258

 

3,136

 

16,087

 

General and administrative

 

3,667

 

5,858

 

12,327

 

14,905

 

Amortization of deferred costs related to warrants

 

 

841

 

1,831

 

2,788

 

Restructuring costs

 

86

 

4,412